BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 17331419)

  • 1. Expression of metalloproteinases MMP-2 and MMP-9 is associated to the presence of androgen receptor in epithelial ovarian tumors.
    Morales-Vásquez F; Castillo-Sánchez R; Gómora MJ; Almaraz MÁ; Pedernera E; Pérez-Montiel D; Rendón E; López-Basave HN; Román-Basaure E; Cuevas-Covarrubias S; Maldonado-Cubas J; Villa A; Mendez C
    J Ovarian Res; 2020 Jul; 13(1):86. PubMed ID: 32718331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma.
    Cai MY; Zhang B; He WP; Yang GF; Rao HL; Rao ZY; Wu QL; Guan XY; Kung HF; Zeng YX; Xie D
    Cancer Sci; 2010 Jun; 101(6):1543-9. PubMed ID: 20367640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of INPP4B is Associated with Poor Prognosis in Epithelial Ovarian Carcinoma.
    Jiang L; Wang J
    Int J Gen Med; 2024; 17():1059-1072. PubMed ID: 38525069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of KiSS-1 and MMP-2 expression levels in breast cancer tissue in evaluating prognosis of elderly breast cancer patients after modified radical mastectomy.
    Lv J; Zhang J; Wu F
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):254-259. PubMed ID: 38650158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of MMP-14 in ovarian cancer: a systematic review.
    Vos MC; van der Wurff AAM; van Kuppevelt TH; Massuger LFAG
    J Ovarian Res; 2021 Aug; 14(1):101. PubMed ID: 34344453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KISS1 protein expression is associated with worse prognosis in osteosarcoma patients: a long-term follow-up study.
    Chen H; Chen P; Lin F; Chen S; Lin J
    Transl Cancer Res; 2019 Sep; 8(5):1756-1762. PubMed ID: 35116926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential roles for the kisspeptin/kisspeptin receptor system in implantation and placentation.
    Hu KL; Chang HM; Zhao HC; Yu Y; Li R; Qiao J
    Hum Reprod Update; 2019 May; 25(3):326-343. PubMed ID: 30649364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kisspeptin/Kisspeptin Receptor System in the Ovary.
    Hu KL; Zhao H; Chang HM; Yu Y; Qiao J
    Front Endocrinol (Lausanne); 2017; 8():365. PubMed ID: 29354093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kisspeptin signalling in the physiology and pathophysiology of the urogenital system.
    Wahab F; Atika B; Shahab M; Behr R
    Nat Rev Urol; 2016 Jan; 13(1):21-32. PubMed ID: 26620614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kisspeptin/KISS1R System in Breast Cancer.
    Cvetković D; Babwah AV; Bhattacharya M
    J Cancer; 2013 Sep; 4(8):653-61. PubMed ID: 24155777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function.
    Kirby HR; Maguire JJ; Colledge WH; Davenport AP
    Pharmacol Rev; 2010 Dec; 62(4):565-78. PubMed ID: 21079036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of phosphorylated protein kinase B and PTEN protein in ovarian epithelial cancer].
    Qiao YH; Cheng J; Guo RX
    Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):325-9. PubMed ID: 17673045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors.
    Kmet LM; Cook LS; Magliocco AM
    Cancer; 2003 Jan; 97(2):389-404. PubMed ID: 12518363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metastatic malignant melanoma of the ovary].
    Tribbia G; Pezzica E; Buzzi A; Crescini C; Sonzogni A
    Minerva Ginecol; 1996 Apr; 48(4):159-62. PubMed ID: 8767559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of KiSS-1, matrix metalloproteinase-9, nuclear factor-kappaBp65 in ovarian tumour].
    Gao GL; Liu LD; Zou XS; Chen WX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):34-8. PubMed ID: 17331419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased staining for phosphorylated AKT and nuclear factor-kappaB p65 and their relationship with prognosis in epithelial ovarian cancer.
    Guo RX; Qiao YH; Zhou Y; Li LX; Shi HR; Chen KS
    Pathol Int; 2008 Dec; 58(12):749-56. PubMed ID: 19067848
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.